Search research articles
Contact Us
Filters
Showing results (81-90 of 137) with videos related to
Page
of 14
Sort By:
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
November 19, 2018
Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study
Chen-Hua Liu, Ming-Lung Yu, Cheng-Yuan Peng, et al.
The Kaohsiung Journal of Medical Sciences
|
January 10, 2023
Clinical prognosis of surgical resection versus transarterial chemoembolization for single large hepatocellular carcinoma (≥5 cm): A propensity score matching analysis
Pei-Min Hsieh, Pojen Hsiao, Yaw-Sen Chen, et al.
Alimentary Pharmacology & Therapeutics
|
October 27, 2018
Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in Taiwan
Chen-Hua Liu, Ming-Lung Yu, Cheng-Yuan Peng, et al.
Journal of Gastroenterology and Hepatology
|
February 20, 2019
Safety and efficacy of elbasvir/grazoprevir in Asian participants with hepatitis C virus genotypes 1 and 4 infection
Lai Wei, Hiromitsu Kumada, Ponni V Perumalswami, et al.
Viruses
|
November 27, 2021
Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan
Chun-Ming Hong, You-Yu Lin, Chun-Jen Liu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
February 7, 2023
TASL, TADE, and DAROC consensus for the screening and management of hepatitis C in patients with diabetes
Ming-Lung Yu, Chih-Yuan Wang, Mei-Hsuan Lee, et al.
Hepatology International
|
July 26, 2015
Aligning to the sample-specific reference sequence to optimize the accuracy of next-generation sequencing analysis for hepatitis B virus
Wen-Chun Liu, Chih-Peng Lin, Chun-Pei Cheng, et al.
The Journal of Infectious Diseases
|
May 13, 2020
High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing Chemotherapy
Wei-Yuan Chang, Yen-Cheng Chiu, Fang-Wei Chiu, et al.
Cancer Immunology, Immunotherapy : CII
|
January 7, 2021
Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
Hong-Ming Tsai, Meng-Zhi Han, Yih-Jyh Lin, et al.
Plos One
|
September 15, 2015
Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients
Chi-Chieh Yang, Wei-Lun Tsai, Wei-Wen Su, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 137) with videos related to
Sort By:
Page
of 14
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
November 19, 2018
Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study
Chen-Hua Liu, Ming-Lung Yu, Cheng-Yuan Peng, et al.
The Kaohsiung Journal of Medical Sciences
|
January 10, 2023
Clinical prognosis of surgical resection versus transarterial chemoembolization for single large hepatocellular carcinoma (≥5 cm): A propensity score matching analysis
Pei-Min Hsieh, Pojen Hsiao, Yaw-Sen Chen, et al.
Alimentary Pharmacology & Therapeutics
|
October 27, 2018
Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in Taiwan
Chen-Hua Liu, Ming-Lung Yu, Cheng-Yuan Peng, et al.
Journal of Gastroenterology and Hepatology
|
February 20, 2019
Safety and efficacy of elbasvir/grazoprevir in Asian participants with hepatitis C virus genotypes 1 and 4 infection
Lai Wei, Hiromitsu Kumada, Ponni V Perumalswami, et al.
Viruses
|
November 27, 2021
Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan
Chun-Ming Hong, You-Yu Lin, Chun-Jen Liu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
February 7, 2023
TASL, TADE, and DAROC consensus for the screening and management of hepatitis C in patients with diabetes
Ming-Lung Yu, Chih-Yuan Wang, Mei-Hsuan Lee, et al.
Hepatology International
|
July 26, 2015
Aligning to the sample-specific reference sequence to optimize the accuracy of next-generation sequencing analysis for hepatitis B virus
Wen-Chun Liu, Chih-Peng Lin, Chun-Pei Cheng, et al.
The Journal of Infectious Diseases
|
May 13, 2020
High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing Chemotherapy
Wei-Yuan Chang, Yen-Cheng Chiu, Fang-Wei Chiu, et al.
Cancer Immunology, Immunotherapy : CII
|
January 7, 2021
Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
Hong-Ming Tsai, Meng-Zhi Han, Yih-Jyh Lin, et al.
Plos One
|
September 15, 2015
Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients
Chi-Chieh Yang, Wei-Lun Tsai, Wei-Wen Su, et al.
Page
of 14